
Jason Mast
@Jasonmmast
Followers
4K
Following
10K
Media
152
Statuses
6K
Writing about science, medicine & business for @statnews Email me: [email protected]
Joined April 2012
RT @matthewherper: I read about an @adamfeuerstein scoop in this @matt_levine column. It is even in the first sentence, and that made my da….
0
2
0
RT @maxdkozlov: Someone else that banned Nature: Nazi Germany. Articles in Nature contain "outrageous and vile attacks on German science an….
0
6
0
RT @adamfeuerstein: Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression h….
0
10
0
RT @matthewherper: This morning, $MRNA released new data on its influenza vaccine. I emailed with two researchers I trust about the data.….
0
12
0
RT @NedPagliarulo: We've updated @BioPharmaDive's 2025 trials to watch list with 10 readouts expected in the second half of the year. A few….
0
2
0
RT @matthewherper: One of @SecKennedy's talking points around medical journals is that Marcia Angell, a former editor of NEJM, said, “We ar….
0
8
0
RT @JohnStreicher1: My NIDA grant renewal is almost 2 months late and I’m going to have to start firing my students and staff. Not a lot of….
0
57
0
RT @statnews: Today is the last day to nominate for #STATWunderkinds! .Wunderkinds is a chance to celebrate early-career researchers who ar….
0
7
0
RT @JasonUkman: A @statnews analysis shows that the gap in NIH grant awards compared to past years has grown over the past two months, to $….
0
13
0
The CDC’s vaccine advisory panel, empowered by RFK Jr., is just getting started via @statnews.
1
11
30
RT @adamfeuerstein: The CDC’s vaccine advisory panel, empowered by RFK Jr., is just getting started via @Jasonmma….
0
2
0
RT @JeromeAdamsMD: 1/.🚨 Over 28 falsehoods and common anti-vaccine talking points were shared during yesterday’s ACIP meeting. The zone is….
0
1K
0
RT @rickberke: SCOOP: NIH halts grant terminations ‘effective immediately,’ email says via @statnews @AnilOza16.
0
6
0
RT @adamfeuerstein: Novo Nordisk $NVO, seen as lagging in obesity drug race, says it’s playing the long game . @elainechen spoke with Novo….
0
5
0
RT @AndrewE_Dunn: Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say. My latest —….
0
17
0
RT @AlexHarding7: There are a couple of limitations of Sana’s clinical stage islet cell program:. 1) This program utilizes cadaveric cells….
0
1
0
RT @adamfeuerstein: Amgen’s $AMGN obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing http….
0
6
0